Malawian caregivers' experiences with HPV vaccination for preadolescent girls: A qualitative study.

HPV vaccine Malawi Vaccine uptake

Journal

Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 08 03 2023
revised: 10 05 2023
accepted: 11 05 2023
medline: 30 5 2023
pubmed: 30 5 2023
entrez: 30 5 2023
Statut: epublish

Résumé

Many low- and middle-income countries have introduced the human papillomavirus (HPV) vaccine, but uptake remains extremely low. Malawi has the second-highest incidence of cervical cancer globally, and launched a national HPV vaccination program in 2019. We sought to understand attitudes about, and experiences with, the HPV vaccine among caregivers of eligible girls in Malawi. We conducted qualitative interviews with 40 caregivers (parents or guardians) of preadolescent girls in Malawi to understand their experiences with HPV vaccination. We coded the data informed by the Behavioural and Social Drivers of vaccine uptake model and recommendations from WHO's Strategic Advisory Group of Experts Working Group on Vaccine Hesitancy. In this sample, 37% of age-eligible daughters had not received any HPV vaccine doses, 35% had received 1 dose, 19% had received 2 doses, and 10% had an unknown vaccination status. Caregivers were aware of the dangers of cervical cancer, and understood that HPV vaccine is an effective prevention tool. However, many caregivers had heard rumors about the vaccine, particularly its alleged harmful effect on girls' future fertility. Many caregivers, especially mothers, felt that school-based vaccination was efficient; but some caregivers expressed disappointment that they had not been more engaged in the school-based delivery of HPV vaccine. Caregivers also reported that the COVID-19 pandemic has been disruptive to vaccination. There are complex and intersecting factors that affect caregivers' motivation to vaccinate their daughters against HPV, and the practical challenges that caregivers may encounter. We identify areas for future research and intervention that could contribute to cervical cancer elimination: better communicating about vaccine safety (particularly to address concerns about loss of fertility), leveraging the unique advantages of school-based vaccination while ensuring parental engagement, and understanding the complex effects of the COVID-19 pandemic (and vaccination program).

Identifiants

pubmed: 37251590
doi: 10.1016/j.jvacx.2023.100315
pii: S2590-1362(23)00056-6
pmc: PMC10208880
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100315

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Corrina Moucheraud reports financial support was provided by University of California Los Angeles Jonsson Comprehensive Cancer Center.

Références

Bull World Health Organ. 2022 Feb 01;100(2):115-126C
pubmed: 35125536
Vaccine. 2022 Mar 31;40 Suppl 1:A58-A66
pubmed: 34275674
Vaccine. 2022 Mar 31;40 Suppl 1:A107-A115
pubmed: 34340857
Health Policy Plan. 2021 Aug 12;36(7):1140-1151
pubmed: 34146394
Prev Med. 2021 Mar;144:106335
pubmed: 33678232
J Health Econ. 2020 Dec;74:102386
pubmed: 33147513
J Community Health. 2012 Oct;37(5):917-26
pubmed: 22302651
Soc Sci Med. 2009 May;68(9):1711-9
pubmed: 19282080
PLoS Med. 2007 Mar;4(3):e73
pubmed: 17388657
PLoS One. 2014 Oct 09;9(10):e109353
pubmed: 25299646
S Afr Med J. 2015 Jan;105(1):40-3
pubmed: 26046162
Lancet Glob Health. 2022 Feb;10(2):e186-e194
pubmed: 34951973
BMJ Glob Health. 2021 Jul;6(7):
pubmed: 34230065
PLOS Glob Public Health. 2023 Jan 4;3(1):e0001394
pubmed: 36962916
Implement Sci. 2018 Dec 13;13(1):151
pubmed: 30545391
Lancet. 2020 Feb 22;395(10224):575-590
pubmed: 32007141
PLOS Glob Public Health. 2022 Oct 21;2(10):e0000628
pubmed: 36962643
Glob Health Res Policy. 2022 Aug 18;7(1):28
pubmed: 35978401
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Vaccine. 2018 Nov 26;36(49):7556-7561
pubmed: 30389192
Public Health Rev. 2020 May 14;41:10
pubmed: 32435520
PLoS One. 2012;7(10):e45231
pubmed: 23115621
Prev Med. 2021 Jul;148:106554
pubmed: 33857561
BMC Public Health. 2016 Aug 19;16(1):834
pubmed: 27543037
Vaccine. 2020 May 19;38(24):4001-4005
pubmed: 32336599
S Afr Med J. 2015 Jan 06;105(2):115-20
pubmed: 26242529
BMC Public Health. 2022 Aug 24;22(1):1611
pubmed: 36002832
Lancet. 2020 Feb 22;395(10224):591-603
pubmed: 32007142
PLoS Med. 2022 Aug 30;19(8):e1004070
pubmed: 36040910
Reprod Health. 2022 Jun 10;19(1):136
pubmed: 35689288
Prev Med. 2020 Feb;131:105968
pubmed: 31881235
Glob Health Sci Pract. 2018 Oct 4;6(3):425-438
pubmed: 30143561
J Cancer Policy. 2022 Jun;32:100321
pubmed: 35560260
Health Econ. 2019 Nov;28(11):1377-1382
pubmed: 31429153
Vaccine. 2021 Aug 31;39(37):5277-5284
pubmed: 34366143

Auteurs

Corrina Moucheraud (C)

Department of Health Policy and Management, Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, 650 Charles E Young Drive S, Los Angeles, CA 90095, USA.

Hannah S Whitehead (HS)

Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.

John Songo (J)

Partners in Hope, Area 36 Plot 8, Lilongwe, Malawi.

Peter G Szilagyi (PG)

Department of Pediatrics, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.

Risa M Hoffman (RM)

Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.

Blessings N Kaunda-Khangamwa (BN)

MAC-Communicable Diseases Action Centre, Kamuzu University of Health Sciences, Queen Elizabeth Central Hospital, Chipatala Avenue, Blantyre, Malawi.
School of Public Health, University of the Witwatersrand, Wits Education Campus, 27 St Andrews Road, Parktown 2193, Johannesburg, South Africa.

Classifications MeSH